Cargando…

Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway

Context: Heart failure (HF) is one of the most serious diseases worldwide. Astragaloside IV (ASI) is widely used for the treatment of cardiovascular disease in China. Objective: To evaluate the protective effect of ASI on the HF in a Sprague–Dawley rat model of left coronary artery ligation, and inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sui, Yan-Bo, Wang, Yu, Liu, Li, Liu, Feng, Zhang, Yi-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871603/ https://www.ncbi.nlm.nih.gov/pubmed/30905241 http://dx.doi.org/10.1080/13880209.2019.1569697

Ejemplares similares

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1
por: Liu, Juan, et al.
Publicado: (2021)

Astragaloside IV Stimulates Angiogenesis and Increases Nitric Oxide Accumulation via JAK2/STAT3 and ERK1/2 Pathway
por: Wang, Shi-Guang, et al.
Publicado: (2013)

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure
por: Sui, Yan-Bo, et al.
Publicado: (2020)

[Corrigendum] Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1
por: Liu, Juan, et al.
Publicado: (2023)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway
por: Li, Bei, et al.
Publicado: (2021)

Astragaloside IV Alleviates the Experimental DSS-Induced Colitis by Remodeling Macrophage Polarization Through STAT Signaling
por: Tian, Lianlian, et al.
Publicado: (2021)

Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells
por: Du, Xiaoxun, et al.
Publicado: (2021)

Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
por: Dong, Zhiwei, et al.
Publicado: (2017)

Accelerated Bone Regeneration by Astragaloside IV through Stimulating the Coupling of Osteogenesis and Angiogenesis
por: Wang, Feng, et al.
Publicado: (2021)

Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway
por: Meng, Yan, et al.
Publicado: (2022)

Photothermal 2D Nanosheets Combined With Astragaloside IV for Antibacterial Properties and Promoting Angiogenesis to Treat Infected Wounds
por: Liu, Lichang, et al.
Publicado: (2022)

Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice
por: Zhou, Ling, et al.
Publicado: (2020)

Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
por: Wu, Suxiao, et al.
Publicado: (2019)

Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure
por: Tang, Bin, et al.
Publicado: (2018)

Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway
por: Jiang, ZhongYu, et al.
Publicado: (2019)

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
por: Xu, ZhengHu, et al.
Publicado: (2021)

Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
por: Gao, Ping, et al.
Publicado: (2021)

Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection
por: Song, Ke, et al.
Publicado: (2023)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway
por: Guo, Li-Hua, et al.
Publicado: (2019)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
por: Li, Lei, et al.
Publicado: (2023)

Astragalus polysaccharides and astragaloside IV alleviate inflammation in bovine mammary epithelial cells by regulating Wnt/β-catenin signaling pathway
por: Fan, Jiaqi, et al.
Publicado: (2022)

Astragaloside IV Alleviates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats
por: Shao, Anwen, et al.
Publicado: (2014)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
por: Zhang, Wen, et al.
Publicado: (2022)

Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
por: Li, Huijun, et al.
Publicado: (2022)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation
por: He, Qiulan, et al.
Publicado: (2020)

Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR-mediated autophagy
por: Zhu, Yunfeng, et al.
Publicado: (2021)

Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia-inducible factor-1α SUMOylation
por: Wang, Baoshen, et al.
Publicado: (2021)

Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway
por: Fan, Cai‐lian, et al.
Publicado: (2022)

Astragaloside IV Alleviates Ammonia-Induced Apoptosis and Oxidative Stress in Bovine Mammary Epithelial Cells
por: Wang, Fengge, et al.
Publicado: (2019)

Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritis
por: ZHANG, Dong, et al.
Publicado: (2022)

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
por: Wan, Jingjing, et al.
Publicado: (2023)

Hypoxia-Induced Activation of JAK/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia
por: Xu, Chengfang, et al.
Publicado: (2017)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g54612rmk72ac52pnn6qnv291o